Urine neutrophil gelatinase-associated lipocalin levels predict acute kidney injury in acute decompensated heart failure patients

Renal Failure

Volumn 37, Issue 5, 2015, Pages 772-776

  Soyler, Canan ^a   Tanriover, Mine Durusu ^b   Ascioglu, Sibel ^b   Aksu, Nalan Metin ^b   Arici, Mustafa ^b  

^a Canakkale Military Hospital   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acute kidney injury; cardiorenal syndrome; diuretic; heart failure; neutrophil gelatinase associated lipocalin

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; FUROSEMIDE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SODIUM; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; AGED; ARTICLE; CARDIAC PATIENT; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DYSPNEA; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; ACUTE KIDNEY INJURY; BLOOD; COMPLICATION; HEART FAILURE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; URINE; VERY ELDERLY;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; BIOMARKERS; FEMALE; FUROSEMIDE; HEART FAILURE; HUMANS; LIPOCALINS; LOGISTIC MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84941031559     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2015.1033324     Document Type: Article

References (31)

1. Weintraub NL, Collins SP, Pang PS, et al. Acute heart failure syndromes: Emergency department presentation, treatment, and disposition: Current approaches and future aims: A scientific statement from the American Heart Association. Circulation. 2010; 122 (19): 1975-1996.
2. Hata N, Yokoyama S, Shinada T, et al. Acute kidney injury and outcomes in acute decompensated heart failure: Evaluation of the RIFLE criteria in an acutely ill heart failure population. Eur J Heart Fail. 2010; 12 (1): 32-37.
3. Damman K, Jaarsma T, Voors AA, Navis G, Hillege HL, van Veldhuisen DJ. Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: Results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J Heart Fail. 2009; 11 (9): 847-854.
4. Felker GM, O'Connor CM, Braunwald E. Loop diuretics in acute decompensated heart failure: Necessary? Evil? A necessary evil? Circ Heart Fail. 2009; 2 (1): 56-62.
5. Cruz DN, de Cal M, Garzotto F, et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med. 2010; 36 (3): 444-451.
6. Ronco C. N-GAL: Diagnosing AKI as soon as possible. Crit Care. 2007; 11 (6): 173.
7. Nickolas TL, O'Rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med. 2008; 148 (11): 810-819.
8. Yndestad A, Landro L, Ueland T, et al. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J. 2009; 30 (10): 1229-1236.
9. Di Somma S, Gori CS, Salvatori E. How to manage cardiorenal syndromes in the emergency room. Contrib Nephrol. 2010; 165: 93-100.
10. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11 (2): R31.
11. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008; 52 (19): 1527-1539.
12. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004; 43 (1): 61-67.
13. Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: A report from the ADHERE database. J Card Fail. 2007; 13 (6): 422-430.
14. Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure: Systematic review and meta-analysis. J Am Coll Cardiol. 2006; 47 (10): 1987-1996.
15. Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005; 149 (2): 209-216.
16. Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P. Differential gene expression following early renal ischemia/reperfusion. Kidney Int. 2003; 63 (5): 1714-1724.
17. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006; 17 (6): 1503-1520.
18. Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol. 2004; 15 (7): 1677-1689.
19. Damman K, Masson S, Hillege HL, et al. Clinical outcome of renal tubular damage in chronic heart failure. Eur Heart J. 2011; 32 (21): 2705-2712.
20. Poniatowski B, Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Dobrzycki S. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease. Kidney Blood Press Res. 2009; 32 (2): 77-80.
21. Koca F, Tanboga IH, Can MM, et al. Neutrophil gelatinase-associated lipocalin levels in right and left heart failure: An observational study. Anadolu Kardiyol Derg. 2011; 11 (6): 498-503.
22. Aghel A, Shrestha K, Mullens W, Borowski A, Tang WH. Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J Card Fail. 2010; 16 (1): 49-54.
23. Alvelos M, Lourenco P, Dias C, et al. Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure. Int J Cardiol. 2011; 165: 51-55.
24. Alvelos M, Pimentel R, Pinho E, et al. Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward. Clin J Am Soc Nephrol. 2011; 6 (3): 476-481.
25. Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009; 4 (2): 337-344.
26. Bolignano D, Basile G, Parisi P, Coppolino G, Nicocia G, Buemi M. Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. Rejuvenation Res. 2009; 12 (1): 7-14.
27. Shrestha K, Borowski AG, Troughton RW, Thomas JD, Klein AL, Tang WH. Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure. J Card Fail. 2011; 17 (6): 472-478.
28. Damman K, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL. Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail. 2008; 10 (10): 997-1000.
29. Damman K, Ng Kam Chuen MJ, MacFadyen RJ, et al. Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. J Am Coll Cardiol. 2011; 57 (22): 2233-2241.
30. Makris K, Markou N, Evodia E, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med. 2009; 47 (1): 79-82.
31. Perry TE, Muehlschlegel JD, Liu KY, et al. Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients. Anesth Analg. 2010; 110 (6): 1541-1547